title: [Cardiac resynchronization therapy].
abstract: Fifteen years after the birth of resynchronization therapy, this technique has become one of the recommended treatments in severe heart failure patients, with low ejection fraction (4 35%), and conduction disorders (ORS > or = 120 ms). Based on large randomized clinical trials, the European recommendation is class I type (level of evidence A), to improve symptoms and survival of this patient population. Recommendations have been extended to patients already implanted with a conventional pacemaker, and to those with chronic atrial fibrillation. Recent results
authors.affiliation: CHU Bordeaux, hôpital cardiologique Haut-Lévêque, 33604 Pessac. sylvain.ploux@chu-bordeaux.fr
authors.forename: Sylvain
authors.initials: S
authors.lastname: Ploux
authors.forename: Pierre
authors.initials: P
authors.lastname: Bordachar
authors.forename: Philippe
authors.initials: P
authors.lastname: Ritter
mesh_terms: D001281:Atrial Fibrillation / Q000628:therapy; D002304:Cardiac Pacing, Artificial; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D010138:Pacemaker, Artificial